Literature DB >> 26825756

Quasi experimental designs in pharmacist intervention research.

Ines Krass1.   

Abstract

Background In the field of pharmacist intervention research it is often difficult to conform to the rigorous requirements of the "true experimental" models, especially the requirement of randomization. When randomization is not feasible, a practice based researcher can choose from a range of "quasi-experimental designs" i.e., non-randomised and at time non controlled. Objective The aim of this article was to provide an overview of quasi-experimental designs, discuss their strengths and weaknesses and to investigate their application in pharmacist intervention research over the previous decade. Results In the literature quasi experimental studies may be classified into five broad categories: quasi-experimental design without control groups; quasi-experimental design that use control groups with no pre-test; quasi-experimental design that use control groups and pre-tests; interrupted time series and stepped wedge designs. Quasi-experimental study design has consistently featured in the evolution of pharmacist intervention research. The most commonly applied of all quasi experimental designs in the practice based research literature are the one group pre-post-test design and the non-equivalent control group design i.e., (untreated control group with dependent pre-tests and post-tests) and have been used to test the impact of pharmacist interventions in general medications management as well as in specific disease states. Conclusion Quasi experimental studies have a role to play as proof of concept, in the pilot phases of interventions when testing different intervention components, especially in complex interventions. They serve to develop an understanding of possible intervention effects: while in isolation they yield weak evidence of clinical efficacy, taken collectively, they help build a body of evidence in support of the value of pharmacist interventions across different practice settings and countries. However, when a traditional RCT is not feasible for logistical and/or ethical reasons researchers should endeavour to use the more robust of the quasi experimental designs.

Keywords:  Pharmaceutical care; Pharmacist intervention; Quasi experimental design; Research

Mesh:

Year:  2016        PMID: 26825756     DOI: 10.1007/s11096-016-0256-y

Source DB:  PubMed          Journal:  Int J Clin Pharm


  53 in total

Review 1.  The use and interpretation of quasi-experimental studies in medical informatics.

Authors:  Anthony D Harris; Jessina C McGregor; Eli N Perencevich; Jon P Furuno; Jingkun Zhu; Dan E Peterson; Joseph Finkelstein
Journal:  J Am Med Inform Assoc       Date:  2005-10-12       Impact factor: 4.497

2.  The expanding scope of pharmacists' practice: implications for physicians.

Authors:  Cara Tannenbaum; Ross T Tsuyuki
Journal:  CMAJ       Date:  2013-08-19       Impact factor: 8.262

3.  Effectiveness of involving pharmacists in the process of ambulatory health care to improve drug treatment adherence and disease control.

Authors:  Dolores Mino-León; Hortensia Reyes-Morales; Sergio Flores-Hernández
Journal:  J Eval Clin Pract       Date:  2014-06-21       Impact factor: 2.431

4.  Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).

Authors:  Ross T Tsuyuki; Sherilyn K D Houle; Theresa L Charrois; Michael R Kolber; Meagen M Rosenthal; Richard Lewanczuk; Norm R C Campbell; Dale Cooney; Finlay A McAlister
Journal:  Circulation       Date:  2015-06-10       Impact factor: 29.690

5.  Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes.

Authors:  Kate L Lapane; Carmel M Hughes; Lori A Daiello; Kathleen A Cameron; Janice Feinberg
Journal:  J Am Geriatr Soc       Date:  2011-06-07       Impact factor: 5.562

6.  Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes.

Authors:  Daniel G Garrett; Benjamin M Bluml
Journal:  J Am Pharm Assoc (2003)       Date:  2005 Mar-Apr

7.  A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes.

Authors:  David Fox; L Douglas Ried; Gary E Klein; Wendy Myers; Kristen Foli
Journal:  J Am Pharm Assoc (2003)       Date:  2009 Mar-Apr

8.  The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.

Authors:  Barry A Bunting; Benjamin H Smith; Susan E Sutherland
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Jan-Feb

9.  The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.

Authors:  I Krass; C L Armour; B Mitchell; M Brillant; R Dienaar; J Hughes; P Lau; G Peterson; K Stewart; S Taylor; J Wilkinson
Journal:  Diabet Med       Date:  2007-06       Impact factor: 4.359

Review 10.  The stepped wedge trial design: a systematic review.

Authors:  Celia A Brown; Richard J Lilford
Journal:  BMC Med Res Methodol       Date:  2006-11-08       Impact factor: 4.615

View more
  4 in total

Review 1.  Selecting and Improving Quasi-Experimental Designs in Effectiveness and Implementation Research.

Authors:  Margaret A Handley; Courtney R Lyles; Charles McCulloch; Adithya Cattamanchi
Journal:  Annu Rev Public Health       Date:  2018-01-12       Impact factor: 21.981

2.  The challenges of outcome research.

Authors:  Lene Juel Kjeldsen; Trine Rune Høgh Nielsen; Charlotte Olesen
Journal:  Int J Clin Pharm       Date:  2016-04-02

3.  Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer.

Authors:  Chimezie Anyakora; Obinna Ekwunife; Faith Alozie; Mopa Esuga; Jonathan Ukwuru; Steve Onya; Jude Nwokike
Journal:  BMC Health Serv Res       Date:  2017-09-18       Impact factor: 2.655

4.  Patient-centered Pharmacist Care in the Hemodialysis Unit: a quasi-experimental interrupted time series study.

Authors:  Sherine Ismail; Abrar Al-Subhi; Eman Youssif; Medhat Ahmed; Abdullah Almalki; Diane L Seger; Andrew C Seger; Earl Cook
Journal:  BMC Nephrol       Date:  2019-11-13       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.